TEL AVIV, Israel, November 25, 2014 /PRNewswire/ --
Elbit Imaging Ltd. ("EI" or the "Company") (TASE,
NASDAQ: EMITF) announced today that it was informed by InSightec
Ltd. ("InSightec") that Japan's Ministry of Health, Labor and Welfare
(MHLW) has approved InSightec's MR-guided Focused Ultrasound
(MRgFUS) system for the treatment of pain palliation caused by bone
metastases and advanced treatment for women with uterine
fibroids. As a result, InSightec may expand its product
portfolio for the Japanese market.
MHLW has also approved the advanced treatment for women with
uterine fibroids. This advanced treatment provides additional
treatment options and shortens treatment time, allowing physicians
to better monitor the procedure.
GE Healthcare is the holder of the above mentioned approval and
distributor of ExAblate in Japan.
The Company holds approximately 89% of the share capital of
Elbit Medical Technologies Ltd. (TASE: EMTC-M) (on a fully diluted
basis) which, in turn, holds approximately 37.6% of the share
capital in InSightec (and 33.3% on a fully diluted basis).
About Elbit Imaging Ltd.
Elbit Imaging Ltd. operates in the following principal fields of
business: (i) Commercial and Entertainment Centers - Initiation,
construction and sale of shopping and entertainment centers and
other mixed-use real property projects, predominantly in the retail
sector, located in Central and Eastern
Europe and in India,
primarily through its subsidiary Plaza Centers N.V. In certain
circumstances and depending on market conditions, the Company
operate and manage commercial and entertainment centers prior to
their sale; (ii) Hotels - Hotel operation and management; (iii)
Medical Industries - (a) research and development, production and
marketing of magnetic resonance imaging guided focused ultrasound
treatment equipment and (b) development of stem cell population
expansion technologies and stem cell therapy products for
transplantation and regenerative medicine; (iv) Residential
Projects - Initiation, construction and sale of residential
projects and other mixed-use real property projects, predominately
residential, located primarily in India; and (v) Fashion Apparel - Distribution
and marketing of fashion apparel and accessories in Israel.
Safe Harbor Statement under the Private Securities Litigation
Reform Act of 1995
Any forward-looking statements in our releases include
statements regarding the intent, belief or current expectations of
Elbit Imaging Ltd. and our management about our business, financial
condition, results of operations, and its relationship with its
employees and the condition of our properties. Words such as
"believe," "would," "expect," "intend," "estimate" and similar
expressions are intended to identify forward-looking statements but
are not the exclusive means of identifying such statements. Actual
results may differ materially from those projected, expressed or
implied in the forward-looking statements as a result of various
factors including, the expansion of InSigthec's product portfolio
in Japan, without limitation, the
factors set forth in our filings with the Securities and Exchange
Commission including, without limitation, Item 3.D of our annual
report on Form 20-F for the fiscal year ended December 31, 2013, under the caption "Risk
Factors." Any forward-looking statements contained in our releases
speak only as of the date of such release, and we caution existing
and prospective investors not to place undue reliance on such
statements. Such forward-looking statements do not purport to be
predictions of future events or circumstances, and therefore, there
can be no assurance that any forward-looking statement contained
our releases will prove to be accurate. We undertake no obligation
to update or revise any forward-looking statements.
For Further Information:
Ron Hadassi
Chairman and Acting CEO
Tel: +972-3-608-6048
ron@elbitimaging.com
SOURCE Elbit Imaging Ltd.